Regeneron Pharmaceuticals (REGN)

Change in Working Capital

$392.40M

TTM · Period ending: · USD

REGN logo

REGN Change in Working Capital

Latest reported$392.40M
REGN TTM Change in Working Capital ($1.50M → $392.40M)
High-resolution chart · PNG

REGN change in working capital history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Change in Working Capital — Trailing twelve months (TTM) (USD)
Period endingChange in Working Capital (USD)
4,421,000
-1,709,000
-15,254,000
-11,739,000
-13,093,000
-8,966,000
1,200,000
-6,100,000
2,600,000
-6,700,000
-7,400,000
-4,600,000
-10,100,000
-4,100,000
-2,600,000
-1,000,000
-3,500,000
-5,200,000
-8,500,000
-7,700,000
-13,000,000
-12,000,000
-14,800,000
-26,700,000
-22,800,000
-8,100,000
-3,000,000
5,100,000
11,700,000
300,000
3,100,000
3,300,000
3,300,000
2,200,000
1,500,000
3,000,000
300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.